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It is noteworthy that micronutrient mal-
nutrition, including iron (Fe) deﬁciency
(ID), is usually highly prevalent in malaria
endemic areas. Since the 1960s, it was
believed that micronutrient deﬁciencies
are associated with increased morbidity
and mortality from malaria and that
malaria, in turn, may contribute to poor
nutritional status, thus reﬂecting the
classic vicious cycle of malnutrition and
infection [1].
Worldwide, ID (usually deﬁned as
a ferritin level ,12 lg/L) is the most
prevalent nutritional deﬁciency, affecting
over 2 billion people [2]. Infants, women
of childbearing age, and preschool-aged
children are particularly affected because
Fe requirements increase during growth,
pregnancy, and lactation.
The treatment of ID, which usually
includes Fe supplementation, represents
one of the priority areas within the
W o r l dH e a l t hO r g a n i z a t i o nm i c r o n u t r i e n t
initiative program. However, iron
supplementation is still a contentious issue
because there is fear that it will lead to
detrimental effects on plasmodial in-
fections. This is in line with the nutritional
immunity theory, which was developed
based on bacterial infection studies that
observed a protective effect of ID on
disease severity [3]. This theory suggests
that depriving the parasite of essential
nutrients such as Fe creates an unfavor-
able internal environment, thus prevent-
ing the parasite from full proliferation.
However, the mechanism(s) involved is
not fully understood and remains to be
elucidated.
With regard to Fe deﬁciency/supple-
mentation in the face of infection with
malaria, various conﬂicting disease out-
comes have been reported from different
studies. Oppenheimer et al [4] and more
recently Sazawal et al [5] demonstrated
that Fe supplementation increased the
risk of malaria among children in en-
demic areas. Although malaria risks were
not increased in some other Fe supple-
mentation trials, these results have raised
concern over routine Fe supplementation
programs in malarious areas [6, 7].
In this issue of Clinical Infectious
Diseases, Gwamaka and colleagues, recog-
nizing that remarkably few studies have
examined the relationship between Fe
status and malaria in unsupplemented
populations, present a study that sought
to evaluate the impact of physiologic
Fe on the risk of malaria [8]. The study
claims that, together with antibody-
mediated immunities against infection
and disease acquired with age, ID provi-
des strong protection against parasitemia
and malaria-associated morbidity and
mortality during childhood.
They used a well-deﬁned cohort of
m o t h e r sa n dt h e i rc h i l d r e ni nT a n z a n i a ,
whom they followed up for up to 3 years.
They ﬁrst identiﬁed a high prevalence of
ID in their birth cohort, which far exceeds
that reported from healthy European
children but is consistent with previous
results. The proportion of mothers with
ID at delivery was similarly high. Why is
the prevalence of ID so high in the chil-
dren and mothers in the study area?
The authors speculated that this concor-
dance may reﬂect a shared Fe-poor diet
or inherited mutations in Fe metabolism.
In the latter possibility, the genetic poly-
morphisms related to Fe transport, stor-
age, regulation, or heme synthesis might
have been selected by malaria, resulting
in a balance between ID anemia and
protection against malaria disease in ac-
cordance with malaria hypothesis. Con-
cerning an Fe-poor diet, one thing we
do not know is if all infants were breast-
fed, and if they were, for how long.
Breastfeeding would help to explain
the high prevalence of ID recorded
in this group. The income/education of
the mothers would also be related to the
diet, especially in such a setting. The
study considered the effects of confound-
ing factors, such as sickle cell status,
but, nevertheless, it failed to look out
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minthic infections, such as hookworm. It
would also have been informative if the
study considered the effects of other mi-
cronutrients such as vitamin A, which is
an essential nutrient for the hemato-
poietic system and is known to have an
effect on Fe uptake. These factors should
be included in future studies.
The determination of ID using either
hematological or biochemical parameters
(including serum Fe, ferritin, transferrin,
and soluble transferrin receptor) is often
difﬁcult, particularly in malaria-endemic
regions, because they are both affected
by infections, including malaria itself
as well as other infections or inﬂamma-
tion. As such, some inﬂamed individuals
with ID will be misclassiﬁed as Fe replete.
This study effectively addressed this po-
tential misclassiﬁcation in several ways,
including the establishment of separate
threshold levels of ferritin for inﬂamed
a n dn o n i n ﬂ a m e dI Ds u b j e c t s ,b ym e a -
suring C-reactive protein levels or by
the restriction of analyses of concurrent
Fe status and parasitemia to samples
obtained during nonsick visits.
Overall, the study clearly shows that
malaria risk is inﬂuenced by physiologic
Fe status and that Fe supplementation
may have adverse effects, even among
children with ID. What do these results
mean for the primary healthcare activi-
ties targeting children at peripheries in
Sub-Saharan Africa, where both ID and
malaria are common?
Iron deﬁciency and malaria both have
serious hematological consequences, and
ID anemia is associated with growth
failure (both physical and intellectual)
in children. An understanding of the
interaction between the 2 may provide
better insight into public health strategies
targeted toward their control. As such,
intervention against both ID and ma-
laria would require integrated and syn-
ergistic approaches. In this context, Fe
supplementation together with inten-
sive deployment of effective intervention
tools, such as artemisinin-combination
treatment and insecticide-treated bed
nets, would be an attractive option. Iron
supplementation programs can be more
safely conducted if early diagnosis and
treatment for malaria cases functions
well. Especially, in circumstances where
current scaled-up control activities have
already decreased malaria morbidity and
mortality or where malaria elimination
has already been integrated into the
healthcare agenda, there should not be
any reservation for Fe supplementation
because an ID status is no longer required
for protection against malaria disease.
Effective control would also require the
diagnosis and treatment of other un-
derlying causes of ID and anemia, thus
highlighting the importance of treatment
programs for other coinfections, in-
cluding human immunodeﬁciency virus
and helminthic infections, and other
micronutrient deﬁciencies. This should
take into account the speciﬁc etiology
and prevalence of ID in a given setting
and population group. And, of course,
the sustainability of any control pro-
gram would be critical.
Studies focused on assessing the effect of
both targeted and community-based mi-
cronutrient interventions on disease out-
come, especially in the groups most at risk,
would also be of critical importance. These
studies should take into consideration the
transmission intensity and prevalence of
malaria infection, prevalence of ID (if of
public health relevance for community
intervention or not), general nutrition, and
prevalence of hemoglobinopathies and
other infections. Improvements in di-
agnostic tools to distinguish ID ane-
mia from anemia of inﬂammation/
chronic disease are also necessary.
In conclusion, although the beneﬁts of
Fe supplementation have generally been
considered to outweigh the potential as-
sociated risks, Gwamaka et al highlight
the fact that caution is required, because
supplementation might carry the risk of
increased severity of disease in the pres-
ence of malaria. However, the following
questions still remain to be addressed:
 How should Fe be delivered—via oral
administration, parenteral
administration, or food fortiﬁcation
programs?
 What dose of Fe supplementation is
both safe and effective?
 What is the optimal duration of Fe
supplementation in order to observe
an appreciable effect/response?
 Does Fe supplementation affect the
course of other infections aside from
malaria?
 Is there any interaction between ID
and other micronutrient deﬁciencies,
such as vitamin A and zinc, per se?
 In areas where malaria prevalence and
mortality is on the decrease, would the
same strategy be relevant? What are
the changes that would be required?
Whatever the decision, whether to sup-
plement or not, the beneﬁts need to be
optimized in order to minimize risk.
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